Back to results
US 2014/0274961 A1Published application
Compounds and uses thereof for the modulation of hemoglobin
AssigneeGlobal Blood Therapeutics, Inc.
InventorsBrian W. Metcalf, Jason R. Harris, Zhe Li, Stephen L. Gwaltney, II
Life of this patent
Estimating the term…
Abstract
Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
Claims8
A compound of formula (I):
- or an N oxide thereof, or a pharmaceutically acceptable salt of each thereof, wherein
- A is selected from the group consisting of:
- wherein R1 is C1-C6 alkyl optionally substituted with 3-6 fluoro atoms;
- R2 is hydrogen or C1-C6 alkyl;
- R3 is C1-C6 alkyl;
- each R4 independently is hydrogen or C1-C6 alkyl;
- ring B is
- or ring B together with A is:
- X is oxygen, S, SO, or SO2;
- ring C is selected from the group consisting of:
- wherein R5 is selected from the group consisting of hydrogen;
- C1-C6 alkoxy, optionally substituted with a C1-C6 alkoxy group or with up to 3 fluoro atoms;
- C1-C6 alkyl;
- and halo;
- R6 is hydrogen or halo;
- R is hydrogen, a phosphate, a diphosphate, a phosphonate or a phosphoramidate containing moiety, or another promoiety;
- provided that the compound of formula (I) comprises at least 1 OR group where R is not hydrogen.
14 more elements
A compound of formula (II):
- wherein R is phosphate, C(O)(CH2)mNR34R35, or C(O)O(CH2)mNR34R35;
- and
- wherein m, R1, R34 and R35 are defined as tabulated below:
- R
- R1
- m
- R34
- R35
- NR34R35
- C(O)(CH2)mNR34R35
- iso-
- 2
- Me
- Me
- propyl
- C(O)(CH2)mNR34R35
- iso-
- 3
- Me
- Me
- propyl
- C(O)(CH2)mNR34R35
- iso-
- 4
- Me
- Me
- propyl
- C(O)(CH2)mNR34R35
- iso- propyl
- 2
- C(O)(CH2)mNR34R35
- iso- propyl
- 3
- C(O)(CH2)mNR34R35
- iso- propyl
- 4
- C(O)O(CH2)mNR34R35
- iso-
- 2
- Me
- Me
- propyl
- C(O)O(CH2)mNR34R35
- iso-
- 3
- Me
- Me
- propyl
- C(O)O(CH2)mNR34R35
- iso-
- 4
- Me
- Me
- propyl
- C(O)O(CH2)mNR34R35
- iso- propyl
- 2
- C(O)O(CH2)mNR34R35
- iso- propyl
- 3
- C(O)O(CH2)mNR34R35
- iso- propyl
- 4
- P(O)(OH)2
- iso- propyl
- an N oxide thereof, or a pharmaceutically acceptable salt of each thereof.
63 more elements
Dependencies are inferred from the claim text.